2013
Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face
Hanlon A, Kim J, Leffell DJ. Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face. Journal Of The American Academy Of Dermatology 2013, 69: 1070-1072. PMID: 24238178, DOI: 10.1016/j.jaad.2013.02.032.Peer-Reviewed Original Research
2000
Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis.
Carucci J, Leffell D. Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis. JAMA Dermatology 2000, 136: 1415-6. PMID: 11074712, DOI: 10.1001/archderm.136.11.1415.Peer-Reviewed Original Research
1999
Mohs Surgery: The Informed View
McGovern T, Leffell D. Mohs Surgery: The Informed View. JAMA Dermatology 1999, 135: 1255-1259. PMID: 10522675, DOI: 10.1001/archderm.135.10.1255.Peer-Reviewed Original ResearchCarcinoma, Basal CellHumansMohs SurgeryNeoplasm Recurrence, LocalQuality Assurance, Health CareQuality ControlSkin Neoplasms